Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting

被引:41
作者
Coppola, A
Hughes, J
Esposito, E
Schiavo, L
Meli, R
Diano, S
机构
[1] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
[2] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy
[3] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA
来源
FEBS LETTERS | 2005年 / 579卷 / 21期
关键词
hypothalamus; deiodinase type II; fasting; enzymatic activity; iopanoic acid;
D O I
10.1016/j.febslet.2005.07.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fasting is characterized by disrupted thyroid feedback, with suppressed levels of thyroid hormones and paraventricular thyrotropin releasing hormone (TRH). We found that third ventricle administration of the deiodinase inhibitor, iopanoic acid, dose-dependently reduced deiodinase type II (DII) activity selectively in the hypothalamus. This suppression of DII by iopanoic acid during fasting prevented elevated DII activity and blunted the decline in hypothalamic TRH mRNA levels. Because fasting-induced elevation in hypothalamic DII activity is paralleled by increased hypothalamic T3 concentration, our study suggests that T3 formation by DII in the hypothalamus is the cause of disrupted thyroid feedback during fasting. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4654 / 4658
页数:5
相关论文
共 31 条
[1]  
AKMAYEV IG, 1976, CELL TISSUE RES, V173, P407
[2]  
Blier R, 1972, BRAIN ENDOCRINE INTE, P306
[3]   CONGENITAL HYPOTHYROIDISM, AS STUDIED IN RATS - CRUCIAL ROLE OF MATERNAL THYROXINE BUT NOT OF 3,5,3'-TRIIODOTHYRONINE IN THE PROTECTION OF THE FETAL BRAIN [J].
CALVO, R ;
OBREGON, MJ ;
DEONA, CR ;
DELREY, FE ;
DEESCOBAR, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :889-899
[4]   Inverse shift in circulating corticosterone and leptin levels elevates hypothalamic deiodinase type 2 in fasted rats [J].
Coppola, A ;
Meli, R ;
Diano, S .
ENDOCRINOLOGY, 2005, 146 (06) :2827-2833
[5]   SUBCELLULAR-LOCALIZATION OF THYROXINE 5'-DEIODINASE ACTIVITY IN BOVINE ANTERIOR-PITUITARY [J].
COURTIN, F ;
PELLETIER, G ;
WALKER, P .
ENDOCRINOLOGY, 1985, 117 (06) :2527-2533
[6]   AN ANALYSIS OF THE SOURCES AND QUANTITY OF 3,5,3'-TRIIODOTHYRONINE SPECIFICALLY BOUND TO NUCLEAR RECEPTORS IN RAT CEREBRAL-CORTEX AND CEREBELLUM [J].
CRANTZ, FR ;
SILVA, JE ;
LARSEN, PR .
ENDOCRINOLOGY, 1982, 110 (02) :367-375
[7]   Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus [J].
Diano, S ;
Naftolin, F ;
Goglia, F ;
Horvath, TL .
ENDOCRINOLOGY, 1998, 139 (06) :2879-2884
[8]   Hypothalamic type II iodothyronine deiodinase: a light and electron microscopic study [J].
Diano, S ;
Leonard, JL ;
Meli, R ;
Esposito, E ;
Schiavo, L .
BRAIN RESEARCH, 2003, 976 (01) :130-134
[9]   Segregation of the intra- and extrahypothalamic neuropeptide Y and catecholaminergic inputs on paraventricular neurons, including those producing thyrotropin-releasing hormone [J].
Diano, S ;
Naftolin, F ;
Goglia, F ;
Horvath, TL .
REGULATORY PEPTIDES, 1998, 75-6 :117-126
[10]   Monosynaptic pathway between the arcuate nucleus expressing glial type II iodothyronine 5′-deiodinase mRNA and the median eminence projective TRH cells of the rat paraventricular nucleus [J].
Diano, S ;
Naftolin, F ;
Goglia, F ;
Csernus, V ;
Horvath, TL .
JOURNAL OF NEUROENDOCRINOLOGY, 1998, 10 (10) :731-742